Načítá se...
Aripiprazole versus quetiapine in treatment-resistant obsessive–compulsive disorder: a double-blind clinical trial
INTRODUCTION: Around 40–60% of the patients with obsessive–compulsive disorder (OCD) remain unimproved by serotonin reuptake inhibitors (SRIs). Goal of this study was to compare the efficiency and safety of aripiprazole versus quetiapine, in patients with OCD, who did not respond effectively to fluv...
Uloženo v:
| Vydáno v: | Ther Adv Psychopharmacol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4315673/ https://ncbi.nlm.nih.gov/pubmed/25653829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125314560739 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|